Sonoma Pharmaceuticals, INC. (SNOA) SEC Filings — 2024

Filings

• Sonoma Pharmaceuticals Terminates Material Agreement — 8-K · Nov 21, 2024
• Sonoma Pharmaceuticals Files Q2 FY25 10-Q — 10-Q · Nov 7, 2024
• Sonoma Pharmaceuticals Enters Material Definitive Agreement — 8-K · Oct 22, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Sep 20, 2024
• Sonoma Pharmaceuticals Files 8-K with Key Corporate Updates — 8-K · Aug 28, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Aug 23, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Aug 21, 2024
• Sonoma Pharma Annual Meeting Adjourned to Aug 23 — DEFA14A · Aug 15, 2024
• Sonoma Pharmaceuticals Files Q1 2025 10-Q — 10-Q · Aug 8, 2024
• Sonoma Pharma Seeks Stockholder Votes for Annual Meeting — DEFA14A · Jul 24, 2024
• Sonoma Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Jul 1, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Jun 27, 2024
• Sonoma Pharmaceuticals Files 2024 10-K — 10-K · Jun 17, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Apr 9, 2024
• Sonoma Pharmaceuticals Files 8-K — 8-K · Apr 2, 2024
• Sonoma Pharmaceuticals Faces Delisting Notice — 8-K · Mar 22, 2024
• Sonoma Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 8, 2024
• Sonoma Pharmaceuticals, Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 8, 2024
• Sonoma Pharma Confirms Nasdaq Listing for SNOA Common Stock — 8-K · Jan 10, 2024
• Sonoma Pharma Enters Material Definitive Agreement on Jan 5 — 8-K · Jan 9, 2024